Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Klinik Kronborg ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   11.7% 11.0% 10.3% 13.0% 7.5% 3.8% 13.5% 13.5%   Credit score (0-100)   22 22 22 17 31 51 17 17   Credit rating   BB BB BB BB BB BBB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -3.9 -5.4 -5.4 0.0 629 731 0.0 0.0   EBITDA   -3.9 -5.4 -5.4 0.0 564 664 0.0 0.0   EBIT   -3.9 -5.4 -5.4 0.0 564 657 0.0 0.0   Pre-tax profit (PTP)   26.2 44.1 54.5 54.3 657.6 682.3 0.0 0.0   Net earnings   26.2 44.1 54.5 54.3 623.7 539.9 0.0 0.0   Pre-tax profit without non-rec. items   26.2 44.1 54.5 54.3 658 682 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.0   Shareholders equity total   -178 -134 -79.9 -5.1 712 1,308 824 824   Interest-bearing liabilities   730 751 771 715 0.0 0.0 0.0 0.0   Balance sheet total (assets)   552 616 691 710 1,501 1,490 824 824   Net Debt   730 751 771 5.1 -1,423 -1,365 -824 -824     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -3.9 -5.4 -5.4 0.0 629 731 0.0 0.0   Gross profit growth   24.7% -39.4% 0.0% 0.0% 0.0% 16.2% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   552 616 691 710 1,501 1,490 824 824   Balance sheet change%   10.3% 11.6% 12.2% 2.7% 111.6% -0.8% -44.7% 0.0%   Added value   -3.9 -5.4 -5.4 0.0 564.0 663.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 -303 272 384 -359   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 0.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 0.0% 89.7% 90.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.7% 8.0% 9.1% 9.2% 59.4% 47.7% 0.0% 0.0%   ROI %   6.7% 8.0% 9.1% 9.2% 92.2% 70.6% 0.0% 0.0%   ROE %   5.0% 7.5% 8.3% 7.8% 87.7% 53.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   -24.4% -17.9% -10.4% -0.7% 47.4% 87.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -18,908.0% -13,941.5% -14,321.7% 0.0% -252.3% -205.7% 0.0% 0.0%   Gearing %   -409.4% -558.7% -965.2% -13,950.6% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.0% 2.0% 2.0% 1.9% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.0 0.0 0.0 1.0 1.8 7.5 0.0 0.0   Current Ratio   0.0 0.0 0.0 1.0 1.8 7.6 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 709.6 1,422.9 1,365.4 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -730.4 -750.6 -771.1 -714.7 -254.7 198.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0